You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
羅欣藥業(002793.SZ)引進韓國三腔袋腸外營養液產品
格隆匯 10-26 12:17

格隆匯10月26日丨羅欣藥業(002793.SZ)宣佈,公司子公司山東羅欣與韓國JW公司於2020年10月26日簽署了《許可協議》,就引進含魚油的三腔袋腸外營養液Winuf®產品達成協議,山東羅欣將獲得該產品在中國(包括中國香港和澳門特別行政區)的獨家開發和商業化的權利。

Winuf®是韓國JW公司研發的三腔袋腸外營養液產品,於2013年被韓國食品藥品管理局(MFDS)批准用於治療無法口服或胃腸道營養供應不充分或受限制,需要通過靜脈供應營養的患者。截至目前已在18個歐洲國家獲得上市批准,商品名為Finomel®。

三腔袋是將脂肪乳、氨基酸和葡萄糖,分別裝入隔成三個相對獨立腔室的特製軟袋,使用時擠壓軟袋,中間間隔打開,三種液體很快充分混合。三腔袋能夠較好地體現“全合一”輸注腸外營養理念,與分瓶輸注營養液和人工配製營養液綜合比較有減少污染、減少人力等較多優勢。

根據IQVIA數據,國內2019年脂肪乳市場招標價銷售額約49億元人民幣,其中品牌三腔袋腸外營養液用量佔比約為14%,遠低於同期歐洲市場77%的佔比,含魚油的三腔袋腸外營養液目前國內市場暫無產品上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account